Akademikliniken

Akademikliniken is a leading provider of aesthetic plastic surgery and advanced skincare treatments, dedicated to enhancing physical appearance through a broad spectrum of surgical and non-surgical options. Founded in 1991 in Stockholm, Sweden, Akademikliniken specializes in aesthetic plastic surgery and skincare treatments. The company has undergone a significant change in ownership, with Polaris Private Equity acquiring a majority stake in May 2016. The acquisition was completed in June 2016.

The clinic has performed over 30,000 breast surgeries, demonstrating its extensive experience in the field. Akademikliniken offers a comprehensive range of aesthetic services including surgical procedures like breast augmentation, facelifts, and body contouring, alongside non-surgical treatments such as injectables and laser treatments. Their product line, AK Skin Care, complements these services, enhancing client satisfaction and results. For the fiscal year 2024, Akademikliniken reported a revenue of USD 22.

18 mn and an EBITDA of USD 773,485. Revenue is generated through direct-to-consumer transactions, with a pricing structure based on individual treatments and promotional offers for skincare products. Akademikliniken aims to expand its service offerings and geographic reach, focusing on new markets in the Nordic region. The recent acquisition by Polaris Private Equity will facilitate these initiatives.

Funding will support the development and launch of new products, although specific upcoming releases have not been disclosed.